- Home
- CBAN vs HQL Comparison
CBAN vs HQL Comparison
Compare CBAN & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CBAN | HQL |
|---|---|---|
| Founded | 1975 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 436.3M | 492.8M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | CBAN | HQL |
|---|---|---|
| Price | $20.06 | $16.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 146.9K | 130.0K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | 2.42% | ★ 11.56% |
| EPS Growth | ★ 9.68 | N/A |
| EPS | ★ 1.17 | 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | $33.81 | N/A |
| Revenue Next Year | $5.43 | N/A |
| P/E Ratio | ★ $16.99 | $21.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.99 | $10.55 |
| 52 Week High | $21.46 | $17.80 |
Technical Indicators
Market Signals| Indicator | CBAN | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 37.10 |
| Support Level | $15.96 | $15.67 |
| Resistance Level | $21.46 | $17.46 |
| Average True Range (ATR) | 0.64 | 0.26 |
| MACD | -0.13 | -0.07 |
| Stochastic Oscillator | 28.20 | 10.41 |
Price Performance
Historical ComparisonAbout CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.